FDAFDA · Food and drugs·Recall number D-0324-2021
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Published April 14, 2021 · Recall initiated: March 31, 2021
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- GUANFACINE EXTENDED-RELEASE
- Manufacturer
- Apotex Corp.
- Distributor
- Nationwide within the United States
- UPC
- 360505392810
- Lot
- Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.